Subsequent (Details Narrative) - USD ($) |
1 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Nov. 12, 2020 |
Nov. 10, 2020 |
Aug. 15, 2020 |
Nov. 04, 2020 |
Nov. 03, 2020 |
Oct. 05, 2020 |
Sep. 30, 2020 |
Dec. 31, 2019 |
|
| Common stock par value | $ 0.001 | $ 0.001 | ||||||
| October 1, 2020 [Member] | ||||||||
| Fee payable | $ 111,540 | |||||||
| Rent | $ 7,000 | |||||||
| Description of rent period | rental rate of approximately $7,000 (£5,400) per month for a period of 16 months until January 31, 2022. The Company can terminate the office lease 90 days before the end of the term without penalty. | |||||||
| Novis Animal Solutions LLC [Member] | ||||||||
| Legal fees | $ 20,000 | |||||||
| Subsequent Event [Member] | ||||||||
| Initial projects agreement term | the agreement relating to Non-Hodgkin’s Lymphoma obligate the Company to pay an aggregate of up to $2.9 million over a period of 22 months. Such payment obligations are on a project-by-project basis as deliverables are executed and subject to certain terms and conditions. Additionally, the Company may terminate the agreement or any project with or without cause upon at least 30 days’ prior written notice. Unless earlier terminated, the term of the agreement is until December 31, 2025 or such later date as when all projects have been completed. | |||||||
| Subsequent Event [Member] | Consulting Services Agreement [Member] | Novis Animal Solutions LLC [Member] | ||||||||
| Claim amount | $ 19,000 | |||||||
| Subsequent Event [Member] | Equity Distribution Agreement [Member] | ||||||||
| Common stock, shares sold | 133,122 | |||||||
| Proceeds from sale of common stock | $ 471,600 | |||||||
| Subsequent Event [Member] | Mr Reynolds [Member] | ||||||||
| Monthly fee | $ 35,650 | |||||||
| Preface S. [Member] | Subsequent Event [Member] | ||||||||
| Company borrowed amount | $ 973,000 | |||||||
| Interest Rate | 4.00% | |||||||
| Description of term | repayable over 5 years with a grace period of 6 months to finance the acquisition and construction of the production facility in Belgium. | |||||||
| Distribution Agreement [Member] | Subsequent Event [Member] | ||||||||
| Aggeregate share of common stock offering price | 25,000,000 | |||||||
| Legal fees | $ 50,000 | |||||||
| Common stock par value | $ 0.001 | |||||||